Development of a Treatment-decision Algorithm for Human Immunodeficiency Virus-uninfected Children Evaluated for

Kenneth S Gunasekera1, Elisabetta Walters2, Marieke M van der Zalm2

  • 1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.

Insights

Developing a diagnostic algorithm using clinical evidence and chest X-rays can improve childhood tuberculosis diagnosis. This approach aids in rapid treatment initiation for more children with tuberculosis, reducing mortality.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Diagnostic Medicine

Background:

  • Childhood tuberculosis diagnosis is hindered by insensitive and inaccessible tools, creating a gap between estimated and notified cases.
  • Accurate and rapid diagnostic tools are crucial for timely antituberculosis treatment initiation in children.

Purpose of the Study:

  • To develop and validate a diagnostic algorithm for childhood pulmonary tuberculosis.
  • To improve the sensitivity and accessibility of tuberculosis diagnosis in children.

Main Methods:

  • Analysis of a prospective cohort of 478 children (<13 years) evaluated for pulmonary tuberculosis in Cape Town, South Africa (2012-2017).
  • Development of a regression model incorporating clinical evaluation, chest radiography, and Xpert MTB/RIF assay results.
  • Standardized, retrospective case definitions were used to classify tuberculosis status.

Main Results:

  • The final algorithm achieved 90.1% sensitivity and 52.1% specificity for diagnosing tuberculosis.
  • Clinical evidence alone identified 71.4% of cases; adding chest radiography increased this to 89.3%.
  • High sensitivity (>90%) was maintained in children <2 years old and those with low weight-for-age.

Conclusions:

  • Clinical evidence is often sufficient for initiating antituberculosis treatment decisions in children.
  • Evidence-based diagnostic algorithms can enhance decentralized and rapid treatment initiation.
  • Improved diagnostic strategies are essential for reducing the global burden of childhood tuberculosis mortality.
Abstract

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
288
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
324
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
509
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
904
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
606
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
108